breakout, page-45

cb

you say....

'The trial remains blinded to everyone else - Avexa included,'

'Avexa had NOTHING to do with the content of the release. They did not choose to omit results about the effectiveness of the drug. They don't have those results and won't get them for a long time yet. The results regarding efficacy etc are due late in 2010.'

If a big pharma has been waiting on early phase 3 results then we're going to be waiting a while for our partnership... and the $20M cash raised will be long gone!

presumably the phase 2b results come into play here??